National Bank of Canada
BVS icon

National Bank of Canada’s Bioventus BVS Stock Holding History

National Bank of Canada’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-800
Closed -$2.09K – 2726
2022
Q4 		$2.09K Hold
800
– – ﹤0.01% 2480
2022
Q3 		$6K Hold
800
– – ﹤0.01% 2300
2022
Q2 		$5K Hold
800
– – ﹤0.01% 2415
2022
Q1 		$11K Hold
800
– – ﹤0.01% 2344
2021
Q4 		$12K Buy
+800
New +$11.4K ﹤0.01% 2294

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

National Bank of Canada's BVS Position: Q1 2023 in Review

National Bank of Canada sold out of Bioventus (BVS) in Q1 2023, closing a stake of 800 shares — an estimated $2.09K sold.

National Bank of Canada first reported a position in BVS in Q4 2021 and held it in 5 quarters. The position peaked at $12K in Q4 2021. 71 funds tracked by Wall St. Rank hold BVS as of Q1 2023.

  • National Bank of Canada reported no remaining Bioventus position as of Q1 2023 after selling out during the quarter.
  • National Bank of Canada sold 800 Bioventus shares in Q1 2023, an estimated $2.09K.
  • National Bank of Canada first reported a position in Bioventus in Q4 2021 and held it in 5 quarters.
  • National Bank of Canada's Bioventus position peaked at $12K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Bioventus as of Q1 2023.

Based on National Bank of Canada's 13F filing for Q1 2023, filed 12 Apr 2023.